Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1977 1
1978 1
1979 1
1980 5
1982 3
1983 5
1984 4
1985 5
1986 5
1987 1
1988 2
1989 2
1990 2
1991 3
1992 7
1993 6
1994 8
1995 8
1996 7
1997 10
1998 9
1999 10
2000 10
2001 10
2002 11
2003 22
2004 10
2005 11
2006 13
2007 17
2008 20
2009 13
2010 18
2011 11
2012 22
2013 16
2014 29
2015 20
2016 22
2017 24
2018 24
2019 45
2020 37
2021 38
2022 19
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

523 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Early Primary Cutaneous T-Cell Non-Hodgkin Lymphoma"
Page 1
Cutaneous T-cell lymphomas-An update 2021.
Kempf W, Mitteldorf C. Kempf W, et al. Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. doi: 10.1002/hon.2850. Hematol Oncol. 2021. PMID: 34105822 Review.
Cutaneous T-cell lymphomas (CTCL) represent the majority of primary cutaneous lymphomas (CL). ...It displays characteristic clinical, histological, and phenotypic features and exhibits an excellent prognosis. Rare, but aggressive CTCL include
Cutaneous T-cell lymphomas (CTCL) represent the majority of primary cutaneous lymphomas (CL). ...It displays cha
Cutaneous T-cell lymphoma: diagnosing subtypes and the challenges.
Hague C, Farquharson N, Menasce L, Parry E, Cowan R. Hague C, et al. Br J Hosp Med (Lond). 2022 Apr 2;83(4):1-7. doi: 10.12968/hmed.2021.0149. Epub 2022 Apr 14. Br J Hosp Med (Lond). 2022. PMID: 35506718 Free article. Review.
Early-stage cutaneous T-cell lymphoma typically follows an indolent course, often being mistaken for benign dermatological conditions which can lead to a diagnostic delay. Advanced stage cutaneous T-cell lymphoma
Early-stage cutaneous T-cell lymphoma typically follows an indolent course, often being mistaken f
Clinicopathologic Variants of Mycosis Fungoides.
Muñoz-González H, Molina-Ruiz AM, Requena L. Muñoz-González H, et al. Actas Dermosifiliogr. 2017 Apr;108(3):192-208. doi: 10.1016/j.ad.2016.08.009. Epub 2016 Nov 18. Actas Dermosifiliogr. 2017. PMID: 27871620 Free article. Review. English, Spanish.
Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma. The clinical course of the disease is typically characterized by progression from a nonspecific phase of erythematous macules to the appearance of plaques and ultimatel …
Mycosis fungoides (MF) is the most common primary cutaneous T-cell lymphoma. The clinical course of the d …
Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy.
Kamijo H, Miyagaki T. Kamijo H, et al. Curr Treat Options Oncol. 2021 Jan 7;22(2):10. doi: 10.1007/s11864-020-00809-w. Curr Treat Options Oncol. 2021. PMID: 33415447 Review.
While most patients with early-stage mycosis fungoides (MF) follow an indolent course, patients with advanced-stage MF/Sezary syndrome (SS) have a poor prognosis with a median survival of less than 5 years. ...The choice of frontline therapy is dependent on t …
While most patients with early-stage mycosis fungoides (MF) follow an indolent course, patients with advanced-stage MF/Sezary …
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, Gniadecki R, Hodak E, Jonak C, Klemke CD, Knobler R, Morrris S, Nicolay JP, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Wehkamp U, Whittaker S, Willemze R, Trautinger F. Latzka J, et al. Eur J Cancer. 2023 Dec;195:113343. doi: 10.1016/j.ejca.2023.113343. Epub 2023 Sep 18. Eur J Cancer. 2023. PMID: 37890355 Free article. Review.
On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 and 2017 this document provides an updated standard for the treatment of mycosis fungoides and Sezary syndrome (MF/SS). ...Still, skin-directe …
On behalf of the EORTC Cutaneous Lymphoma Tumours Group (EORTC-CLTG) and following up on earlier versions published in 2006 an …
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Jawed SI, et al. J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. J Am Acad Dermatol. 2014. PMID: 24438969 Review.
Precise clinicopathologic correlation is necessary to support a diagnosis, especially in the early stages of disease. In addition to the identification of histopathologic criteria, ancillary studies, including the identification of CD4(+) T cells with aberrant immunophenot …
Precise clinicopathologic correlation is necessary to support a diagnosis, especially in the early stages of disease. In addition to …
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, Stingl G, Weninger W, Halbritter F, Bauer WM, Farlik M, Brunner PM. Rindler K, et al. Mol Cancer. 2021 Sep 28;20(1):124. doi: 10.1186/s12943-021-01419-2. Mol Cancer. 2021. PMID: 34583709 Free PMC article.
BACKGROUND: In early-stage mycosis fungoides (MF), the most common primary cutaneous T-cell lymphoma, limited skin involvement with patches and plaques is associated with a favorable prognosis. ...METHODS: In patients with advanced-stage …
BACKGROUND: In early-stage mycosis fungoides (MF), the most common primary cutaneous T-cell lymphoma, lim …
Cutaneous Lymphomas.
Specht L, Skov L. Specht L, et al. Clin Oncol (R Coll Radiol). 2019 Nov;31(11):797-807. doi: 10.1016/j.clon.2019.07.018. Epub 2019 Aug 9. Clin Oncol (R Coll Radiol). 2019. PMID: 31405542 Review.
They have special characteristics compared with other lymphomas. They are most frequently of T-cell origin and they generally have a much more indolent course than lymphomas of similar histology in other locations. Mycosis fungoides is the most common type of …
They have special characteristics compared with other lymphomas. They are most frequently of T-cell origin and they generally …
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, Gniadecki R, Klemke CD, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Whittaker S, Willemze R, Knobler R. Trautinger F, et al. Eur J Cancer. 2017 May;77:57-74. doi: 10.1016/j.ejca.2017.02.027. Epub 2017 Mar 31. Eur J Cancer. 2017. PMID: 28365528 Free article. Review.
In order to provide a common standard for the treatment of mycosis fungoides (MF) and Sezary syndrome (SS), the European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) published in 2006 its consensus recommendations for …
In order to provide a common standard for the treatment of mycosis fungoides (MF) and Sezary syndrome (SS), the European Organisation for Re …
How do we treat cutaneous T-cell lymphoma?
Stranzenbach R. Stranzenbach R. Ital J Dermatol Venerol. 2021 Oct;156(5):534-544. doi: 10.23736/S2784-8671.20.06606-7. Epub 2020 Sep 17. Ital J Dermatol Venerol. 2021. PMID: 32938164 Free article. Review.
Cutaneous T-cell lymphomas are a heterogeneous group of non-Hodgkin lymphomas which are based on the malignant proliferation of skin-related T lymphocytes. ...Considering the current guidelines, literature and subjective experience, we summarize in this revie
Cutaneous T-cell lymphomas are a heterogeneous group of non-Hodgkin lymphomas which are based on the malignant prolifer
523 results